上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物,专注于信号通路和疾病研究领域。
Vanillylmandelic acid (Synonyms: 香草扁桃酸;3-甲氧基-4-羟基扁桃酸) 纯度: 99.90%
Vanillylmandelic acid 是肾上腺素和去甲肾上腺素代谢的最终产物。Vanillylmandelic acid 也可作为神经递质代谢紊乱的标志物。Vanillylmandelic acid 具有抗氧化 (antioxidant) 活性,清除 DPPH 自由基的 IC50 值为 33 μM。
Vanillylmandelic acid Chemical Structure
CAS No. : 55-10-7
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1 – 0.2 mg) | Apply now | ||
10 mM * 1 mL in DMSO | ¥550 | In-stock | |
25 mg | ¥500 | In-stock | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
Vanillylmandelic acid 相关产品
•相关化合物库:
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Metabolism/Protease Compound Library
- Natural Product Library
- Human Endogenous Metabolite Compound Library
- Antioxidant Compound Library
- Anti-Cardiovascular Disease Compound Library
- Phenols Library
- Gut Microbial Metabolite Library
- Microbial Metabolite Library
- Food-Sourced Compound Library
- Drug Metabolite Library
- Human Metabolite Library
- Coagulation and Anti-coagulation Compound Library
- Animal-Sourced Natural Product Library
- Multi-Target Compound Library
- Radioprotector Library
生物活性 |
Vanillylmandelic acid is the endproduct of epinephrine and norepinephrine metabolism. Vanillylmandelic acid can be used as an indication of the disorder in neurotransmitter metabolism as well. Vanillylmandelic acid has antioxidant activity towards DPPH radical with an IC50 value of 33 μM[1]. |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||
体外研究 (In Vitro) |
Vanillylmandelic acid has antioxidant activity, the IC50 value is determined as the amount of VMA required to reduce 50% of the starting concentration of free radical is 33*10-6 M in the UV-Vis decolourisation DPPH assay[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
体内研究 (In Vivo) |
Vanillylmandelic acid (intra-arterial injection over 1 min; 1, 10 and 100 mg/kg; the 60 min-observation period) produces a significant difference between vanillylmandelic acid groups and controls. Vanillylmandelic acid decreases the heart rate by 17.5%, 17.9% and 18.9% after 1, 10 and 100 mg/kg, respectively. Mean blood pressure is decreased by 13.5% in control animals as compared to 37%, 23% and 26% after 1, 10 and 100 mg/kg, respectively, in wistar rats[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
分子量 |
198.17 |
||||||||||||
Formula |
C9H10O5 |
||||||||||||
CAS 号 |
55-10-7 |
||||||||||||
性状 |
固体 |
||||||||||||
颜色 |
White to off-white |
||||||||||||
中文名称 |
香草扁桃酸;3-甲氧基-4-羟基扁桃酸 |
||||||||||||
结构分类 |
|
||||||||||||
初始来源 |
|
||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||
储存方式 |
|
||||||||||||
溶解性数据 |
In Vitro:
DMSO 中的溶解度 : 250 mg/mL (1261.54 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO) H2O 中的溶解度 : 100 mg/mL (504.62 mM; 超声助溶) 配制储备液
查看完整储备液配制表
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 * 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2
In Vivo:
请根据您的 实验动物和给药方式 选择适当的溶解方案。 以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
以下溶解方案,请直接配置工作液。建议现用现配,在短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比; 如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。
动物溶解方案计算器
请输入动物实验的基本信息:
给药剂量 mg/kg 动物的平均体重 g 每只动物的给药体积 μL 动物数量 只 由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
该产品水溶性佳,请具体参考实测 水 / PBS / Saline 中的溶解度数据。
免费服务热线:021-50837765
E-mail:sales@jinpanbio.com 技术支持电话:021-50837765 技术支持邮箱:sales@jinpanbio.com |
||||||||||||
纯度 & 产品资料 |
纯度: 99.90%
Data Sheet (628 KB) SDS (393 KB)
COA (192 KB) LCMS (88 KB) 产品使用指南 (1538 KB) |
||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务